Structure Therapeutics rises on mid-stage data for oral GLP-1
Source: SeekingAlpha
2026-03-16 12:27:40 ET
More on Structure Therapeutics
- Structure Therapeutics: The Dark Horse Has Taken The Lead - But Is It Enough?
- Structure Therapeutics reports Q4 results
- Key deals this week: Apple, McEwen Mining, IonQ, Leidos, and more
- Seeking Alpha’s Quant Rating on Structure Therapeutics
- Historical earnings data for Structure Therapeutics
Read the full article on Seeking Alpha
For further details see:
Structure Therapeutics rises on mid-stage data for oral GLP-1
Structure Therapeutics Inc.
NASDAQ: GPCR
GPCR Trading
0.62% G/L:
$53.57 Last:
188,769 Volume:
$53.50 Open:
GPCR Latest News
GPCR Stock Data
$5,430,883,453
65,267,397
0.07%
67
N/A
Biotechnology & Life Sciences
Healthcare
US
South San Francisco
